Product ID: UCMIG35I2218
Report ID:
UCMIG35I2218 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.
The market for Phenylketonuria Treatment was estimated to be valued at US$ XX Mn in 2021.
The Phenylketonuria Treatment Market is estimated to grow at a CAGR of XX% by 2028.
The Phenylketonuria Treatment Market is segmented on the basis of Drug, Region.
Based on region, the Phenylketonuria Treatment Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Phenylketonuria Treatment Market are BioMarin Pharmaceuticals, Inc., Censa Pharmaceutical, Inc., Retrophin, Inc., Synlogic, Inc., Rubius Therapeutics, Inc., Homology Medicines, Inc..
Product ID: UCMIG35I2218